← FDA Drug Approvals (Drugs@FDA)
ERBITUX
BLA · Biologics License Application · Sponsor: IMCLONE · Approved 2004-02-12
Drug application
- FDA Application #
BLA125084- Application type
- Biologics License Application
- Brand name
- ERBITUX
- Generic name
- CETUXIMAB
- Active ingredients
- CETUXIMAB
- Dosage form
- VIAL
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- IMCLONE
- Manufacturer
- ImClone LLC
- First approval
- 2004-02-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown